Peter Andersen

机构：University of Copenhagen, Odense University Hospital, Office of the Assistant Secretary for Health, University of Health Sciences Antigua · ORCID：0009-0001-4278-3731

发表论文 85 篇 · 总被引 1978 次 · h-index 20

代表论文

• Steatotic Liver Disease Classification Is Dynamic, Affecting Clinical Trial Eligibility and Subclass-Specific Treatments (2025 · Clinical Gastroenterology and Hepatology · 被引 46)
• Development, validation, and prognostic evaluation of LiverPRO for the prediction of significant liver fibrosis in primary care: a prospective cohort study (2024 · ˜The œLancet. Gastroenterology & hepatology · 被引 45)
• Phosphatidylethanol and self-reported alcohol intake to subclassify individuals at risk of steatotic liver disease: an analysis of data from a prospective cohort study (2025 · ˜The œLancet. Gastroenterology & hepatology · 被引 38)
• Prevalence, severity and determinants of steatotic liver disease among individuals with metabolic and alcohol risk from the community (2025 · Journal of Hepatology · 被引 22)
• The postbiotic ReFerm® versus standard nutritional support in advanced alcohol-related liver disease (GALA-POSTBIO): a randomized controlled phase 2 trial (2025 · Nature Communications · 被引 13)
• M et ALD : Diagnosis and Prognosis With Non‐Invasive Tests (2025 · Alimentary Pharmacology & Therapeutics · 被引 11)